A randomized controlled trial on the effectiveness of Metformin for prevention of Preeclampsia in Abubakar Tafawa Balewa University teaching hospital Bauchi, Nigeria.

A randomized controlled trial on the effectiveness of Metformin for preventing preeclampsia in Abubakar Tafawa Balewa University Teaching hospital, Bauchi Nigeria.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202405860574489

Enrollment

140

Registered

2024-05-13

Start date

2023-02-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclamsia

Interventions

Metformin group

Control group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Primigravidae. Gestational age = 20 weeks (from LMP or early scan). Singleton live pregnancy

Exclusion criteria

Exclusion criteria: Primigravidae with history Diabetes Mellitus. Primigravidae with history chronic conditions such as; chronic hypertension, chronic renal disease, thyroid disease in pregnancy, systemic lupus erythromatosus. Known allergy to metformin.

Design outcomes

Primary

Measure	Time frame
Incidence of Preeclampsia Severity of Preeclampsia Gestational age at onset of Preeclampsia Gestation age at delivery	—

Secondary

Measure	Time frame
Neonatal Apgar score, Birth weight Abortions Eclampsia Abrupio placeante Pregnancy induce hypertension Side effects of metformin;Side effects of metformin	—

Countries

Nigeria

Contacts

Public ContactVenat Dung

Public enquires

ngoyop0437@gmail.com+2437039456646

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026